SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056218
Filing Date
2021-11-10
Accepted
2021-11-10 16:25:55
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hsto-10q_20210930.htm   iXBRL 10-Q 2731724
2 EX-31.1 hsto-ex311_9.htm EX-31.1 21354
3 EX-31.2 hsto-ex312_8.htm EX-31.2 21316
4 EX-32.1 hsto-ex321_6.htm EX-32.1 8685
5 EX-32.2 hsto-ex322_7.htm EX-32.2 8693
  Complete submission text file 0001564590-21-056218.txt   9134083

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA hsto-20210930.xsd EX-101.SCH 74577
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hsto-20210930_cal.xml EX-101.CAL 66800
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hsto-20210930_def.xml EX-101.DEF 232542
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20210930_lab.xml EX-101.LAB 554391
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20210930_pre.xml EX-101.PRE 402150
11 EXTRACTED XBRL INSTANCE DOCUMENT hsto-10q_20210930_htm.xml XML 1361489
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 211397064
SIC: 2834 Pharmaceutical Preparations